247 related articles for article (PubMed ID: 34610596)
21. Are Dietary Indices Associated with Polycystic Ovary Syndrome and Its Phenotypes? A Preliminary Study.
Cutillas-Tolín A; Arense-Gonzalo JJ; Mendiola J; Adoamnei E; Navarro-Lafuente F; Sánchez-Ferrer ML; Prieto-Sánchez MT; Carmona-Barnosi A; Vioque J; Torres-Cantero AM
Nutrients; 2021 Jan; 13(2):. PubMed ID: 33499268
[TBL] [Abstract][Full Text] [Related]
22. Substituting poly- and mono-unsaturated fat for dietary carbohydrate reduces hyperinsulinemia in women with polycystic ovary syndrome.
Perelman D; Coghlan N; Lamendola C; Carter S; Abbasi F; McLaughlin T
Gynecol Endocrinol; 2017 Apr; 33(4):324-327. PubMed ID: 27910718
[TBL] [Abstract][Full Text] [Related]
23. Implementing the international evidence-based guideline of assessment and management of polycystic ovary syndrome (PCOS): how to achieve weight loss in overweight and obese women with PCOS?
Lie Fong S; Douma A; Verhaeghe J
J Gynecol Obstet Hum Reprod; 2021 Jun; 50(6):101894. PubMed ID: 32814159
[TBL] [Abstract][Full Text] [Related]
24. Lifestyle changes in women with polycystic ovary syndrome.
Moran LJ; Hutchison SK; Norman RJ; Teede HJ
Cochrane Database Syst Rev; 2011 Jul; (7):CD007506. PubMed ID: 21735412
[TBL] [Abstract][Full Text] [Related]
25. Focus on metabolic and nutritional correlates of polycystic ovary syndrome and update on nutritional management of these critical phenomena.
Rondanelli M; Perna S; Faliva M; Monteferrario F; Repaci E; Allieri F
Arch Gynecol Obstet; 2014 Dec; 290(6):1079-92. PubMed ID: 25200687
[TBL] [Abstract][Full Text] [Related]
26. Does a restricted energy low glycemic index diet have a different effect on overweight women with or without polycystic ovary syndrome?
Shishehgar F; Mirmiran P; Rahmati M; Tohidi M; Ramezani Tehrani F
BMC Endocr Disord; 2019 Sep; 19(1):93. PubMed ID: 31477085
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular risk in women with polycystic ovary syndrome.
Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
[TBL] [Abstract][Full Text] [Related]
28. Polycystic ovary syndrome, obesity and reproductive implications.
Hirschberg AL
Womens Health (Lond); 2009 Sep; 5(5):529-40; quiz 541-2. PubMed ID: 19702452
[TBL] [Abstract][Full Text] [Related]
29. Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility.
Panidis D; Tziomalos K; Papadakis E; Vosnakis C; Chatzis P; Katsikis I
Endocrine; 2013 Dec; 44(3):583-90. PubMed ID: 23625194
[TBL] [Abstract][Full Text] [Related]
30. Higher dietary inflammation potential and certain dietary patterns are associated with polycystic ovary syndrome risk in China: A case-control study.
Wang Q; Sun Y; Xu Q; Liu W; Wang P; Yao J; Zhao A; Chen Y; Wang W
Nutr Res; 2022 Apr; 100():1-18. PubMed ID: 35108617
[TBL] [Abstract][Full Text] [Related]
31. Dietary therapy in polycystic ovary syndrome.
Moran LJ; Brinkworth GD; Norman RJ
Semin Reprod Med; 2008 Jan; 26(1):85-92. PubMed ID: 18181086
[TBL] [Abstract][Full Text] [Related]
32. An isocaloric low glycemic index diet improves insulin sensitivity in women with polycystic ovary syndrome.
Barr S; Reeves S; Sharp K; Jeanes YM
J Acad Nutr Diet; 2013 Nov; 113(11):1523-1531. PubMed ID: 23999280
[TBL] [Abstract][Full Text] [Related]
33. Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome.
Barrea L; Marzullo P; Muscogiuri G; Di Somma C; Scacchi M; Orio F; Aimaretti G; Colao A; Savastano S
Nutr Res Rev; 2018 Dec; 31(2):291-301. PubMed ID: 30033891
[TBL] [Abstract][Full Text] [Related]
34. Effects of Mixed of a Ketogenic Diet in Overweight and Obese Women with Polycystic Ovary Syndrome.
Cincione RI; Losavio F; Ciolli F; Valenzano A; Cibelli G; Messina G; Polito R
Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886216
[TBL] [Abstract][Full Text] [Related]
35. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
[TBL] [Abstract][Full Text] [Related]
36. Lifestyle changes in women with polycystic ovary syndrome.
Moran LJ; Hutchison SK; Norman RJ; Teede HJ
Cochrane Database Syst Rev; 2011 Feb; (2):CD007506. PubMed ID: 21328294
[TBL] [Abstract][Full Text] [Related]
37. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
[TBL] [Abstract][Full Text] [Related]
38. Nonalcoholic fatty liver disease and polycystic ovary syndrome.
Vassilatou E
World J Gastroenterol; 2014 Jul; 20(26):8351-63. PubMed ID: 25024594
[TBL] [Abstract][Full Text] [Related]
39. Management of obesity in adolescents with polycystic ovary syndrome.
Vatopoulou A; Tziomalos K
Expert Opin Pharmacother; 2020 Feb; 21(2):207-211. PubMed ID: 31893931
[No Abstract] [Full Text] [Related]
40. The role of lifestyle modification in polycystic ovary syndrome.
Norman RJ; Davies MJ; Lord J; Moran LJ
Trends Endocrinol Metab; 2002 Aug; 13(6):251-7. PubMed ID: 12128286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
